| TP53 | CEN17 | AML1 | SNRPN | Chromosome 17 | Chromosome 21 |
---|
CON (n = 20) | P > 0.20 | P > 0.10 | P > 0.05 | P > 0.70 | P > 0.60 | P > 0.50 |
ADI (n = 20) | P < 10-13
| P < 10-12
| P < 10-15
| P > 0.50 | P > 0.30 | P > 0.20 |
PRE (n = 14) | P < 10-11
| P < 10-9
| P < 10-6
| ----- | P > 0.10 | P > 0.40 |
- CON - samples of cancer free subjects; ADI - samples of patients with hematological malignancies obtained at diagnosis; PRE - samples of patients with hematological malignancies taken prior to alloSCT; AZA - 5-azacytidine; n - Number of cases tested within each group for each locus/chromosome; SD values - columns 1-4; and aneuploidy levels - columns 4 and 5.